Pediatric Cancer Genetics and Genomics.

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Molecular profiling using next-generation sequencing (NGS) is crucial for pediatric cancer diagnosis and prognosis.
• NGS aids in identifying somatic alterations for targeted therapy selection in pediatric malignancies.
• Routine clinical integration of molecular profiling complements traditional pathology in pediatric cancer care.

Purpose of the Study:

• To highlight the advancements in molecular profiling techniques for pediatric cancers.
• To discuss the role of emerging technologies in characterizing complex genomic alterations.
• To explore the application of computational methods in understanding cancer susceptibility and developing new monitoring approaches.

Main Methods:

• Next-generation sequencing (NGS) for DNA and RNA analysis.
• CRISPR editing technology and functional assays for variant characterization.
• Computational methods including rare variant association studies and polygenic risk scoring.

Main Results:

• Molecular profiling improves diagnosis, prognosis, and targeted therapy identification in pediatric cancers.
• Advanced techniques reveal intricate structural complexity in pediatric cancer genomes, including gene fusions.
• Computational approaches are identifying novel cancer susceptibility genes and risk factors.

Conclusions:

• Molecular profiling is integral to modern pediatric cancer management.
• Technological and analytical advancements are deepening the understanding of pediatric cancer biology.
• Emerging methods like liquid biopsy monitoring show promise for future clinical applications.